Litcius/Paper detail

An observational study of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab

Zequn Tong, Yihua Zhang, Kunli Zhou, Ying Zou, Zhenlan Wu, Jiawen Chen, Zheyu Zhuang, Yi‐Fan Zhao, Ting Gong, Chao Ji

2023Journal of the American Academy of Dermatology15 citationsDOI

Topics & Concepts

DupilumabMedicineAtopic dermatitisEczema Area and Severity IndexDermatologyClinical trialRandomized controlled trialSCORADObservational studyInternal medicinePsoriasisDermatology Life Quality IndexDermatology and Skin DiseasesAsthma and respiratory diseasesUrticaria and Related Conditions
An observational study of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab | Litcius